CD274 and neoplasm: When PD-L1 is overexpressed, effector T cell function is inhibited, which increases tumor cells’ capacity for immune evasion and reduces the effectiveness of immune checkpoint inhibitors such anti-PD-1/PD-L1 antibodies (7).